ACTRN12619000424101尚未招募未知
Pilot study to assess biochemical efficacy of 2 dialysis membranes in the setting of nocturnal haemodialysis.
Monash Health, Clayton, Vic,0 个研究点目标入组 10 人开始时间: 2019年3月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Existing nocturnal haemodialysis patients.
排除标准
- •Those with dialysis difficulties, such as poor Arterio-venous access.
- •Those unwilling to consent.
研究者
相似试验
未知
2 期
Phase 2 study of DS-8500aType 2 Diabetes MellitusJPRN-jRCT2080222546DAIICHISANKYO Co.,Ltd.90
招募中
2 期
Meloxicam in mobilization with Colony stimulating factor (G-CSF) will improve mobilization rates in patients undergoing mobilization for autologous stem cell transplantation.CTRI/2014/06/004671Investigator Initiated Study50
招募中
不适用
A clinical study to investigate the efficacy of diuretics to the HF patients with proteinuria and edema.Heart FailureJPRN-UMIN000006212Social Insurance Yokohama Central Hospital15
进行中（未招募）
1 期
Essai de phase II évaluant l’effet curatif de la pravastatine chez des patients présentant une fibrose cutanée et sous-cutanée radio-induite établie - PravaCURFibrose radio-induite évolutive depuis 6 à 24 mois chez des patients traités par radiothérapie cervico-faciale pour un cancer de la sphère ORL, en guérison maintenueMedDRA version: 12.1 Level: LLT Classification code 10016642 Term: FibrosisEUCTR2009-017000-83-FRInstitut Gustave Roussy40
进行中（未招募）
不适用
Phase II clinical trial exploring the activity of crizotinib in patients with advanced solid tumors induced by causal alterations of specific receptors (ALK and MET/HGF receptor tyrosine kinases) expressed by cancer sells.ocally advanced and/or metastatic malignant tumor (anaplastic large cell lymphoma, inflammatory myofibroblastic tumor, papillary renal cell carcinoma type 1, alveolar soft part sarcoma, clear cell sarcoma or alveolar rhabdomyosarcoma) deemed incurable by conventional surgery, radiotherapy, systemic therapy or any other meansMedDRA version: 15.1Level: LLTClassification code 10065867Term: Alveolar rhabdomyosarcomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 15.1Level: PTClassification code 10002227Term: Anaplastic large cell lymphoma T- and null-cell typesSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 15.1Level: PTClassification code 10001882Term: Alveolar soft part sarcomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 15.1Level: SOCClassification code 10029104Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-001988-52-ITE.O.R.T.C. - EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER582